Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity : a case control study

Peyronnet B1, Evelyne C2, Mathieu R3, Lucie E4, Philippe M2, Michel S2, Pascal R2, Xavier G2

Research Type

Clinical

Abstract Category

Neurourology

Abstract 493
Open Discussion ePosters
Scientific Open Discussion ePoster Session 27
Friday 16th September 2016
12:35 - 12:40 (ePoster Station 3)
ePoster Area
Detrusor Overactivity Conservative Treatment Multiple Sclerosis Spinal Cord Injury
1. Rennes University Hospital, 2. Toulouse University Hospital, 3. Toulouse universty Hospital, 4. Toulouse university Hospital
Presenter
B

Benoit Peyronnet

Links

Abstract